Gain Therapeutics, Inc.
GANX
$1.80
$0.063.45%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -38.16% | -1.50% | 4.59% | -28.94% | -16.60% |
| Total Receivables | 215.66% | 266.73% | 94.90% | 46.01% | 26.82% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -39.20% | 45.36% | 35.06% | -28.65% | -2.60% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -34.74% | 3.77% | 7.11% | -28.26% | -15.71% |
|
|
|||||
| Total Current Assets | -34.74% | 3.77% | 7.11% | -28.26% | -15.71% |
| Net Property, Plant & Equipment | -44.75% | -35.10% | -35.59% | -34.25% | -27.24% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -30.56% | -17.39% | -22.69% | -19.00% | -9.63% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 22.93% | 37.94% | -0.40% | 1.23% | 7.45% |
| Total Assets | -34.85% | 1.90% | 5.12% | -31.63% | -22.78% |
|
|
|||||
| Total Accounts Payable | -28.26% | -20.22% | 121.42% | -36.52% | -18.89% |
| Total Accrued Expenses | 14.77% | -5.83% | 11.62% | -7.46% | 5.60% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -22.21% | -12.72% | -14.25% | -7.70% | 3.35% |
| Total Finance Division Other Current Liabilities | -76.88% | -48.76% | -39.41% | 719.04% | 620.68% |
| Total Other Current Liabilities | -76.88% | -48.76% | -39.41% | 719.04% | 620.68% |
| Total Current Liabilities | -20.98% | -20.28% | 16.73% | -2.93% | 19.99% |
|
|
|||||
| Total Current Liabilities | -20.98% | -20.28% | 16.73% | -2.93% | 19.99% |
| Long-Term Debt | -26.90% | -13.52% | -19.55% | -17.04% | -9.33% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -76.69% | -63.49% | -59.32% | -54.03% | -47.96% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 22.10% | 27.62% | -51.63% | 116.77% | 155.20% |
| Total Liabilities | -20.67% | -19.37% | 3.40% | -4.02% | 15.54% |
|
|
|||||
| Common Stock & APIC | 21.43% | 36.01% | 35.98% | 25.08% | 27.47% |
| Retained Earnings | -33.58% | -38.11% | -42.07% | -48.44% | -57.81% |
| Treasury Stock & Other | -200.12% | 167.70% | -90.69% | -77.26% | 594.38% |
| Total Common Equity | -41.65% | 21.53% | 6.24% | -42.91% | -33.38% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -41.65% | 21.53% | 6.24% | -42.91% | -33.38% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -41.65% | 21.53% | 6.24% | -42.91% | -33.38% |
|
|
|||||